1 | issue | 7,893 |
2 | ex-b | 104 |
3 | gravida | 93 |
4 | ex-le | 22 |
5 | erythroid-derived | 20 |
6 | isar-test | 11 |
7 | anhelto | 6 |
8 | nih/cpsi | 5 |
9 | wn02 | 5 |
10 | postwrap | 4 |
11 | 'stage | 3 |
12 | conservativeness | 3 |
13 | diacetylene | 3 |
14 | neurofunction | 3 |
15 | pappalysin | 3 |
16 | spondin | 3 |
17 | texturing | 3 |
18 | uht-processed | 3 |
19 | wrat | 3 |
20 | 16:1cis | 2 |
21 | 1966-week | 2 |
22 | 1982-week | 2 |
23 | 4-hydroxyacetophenone | 2 |
24 | caspase- | 2 |
25 | e2/e4 | 2 |
26 | evidence.comparison | 2 |
27 | hemeoxygenase | 2 |
28 | junctophilin | 2 |
29 | kinase/pentraxin | 2 |
30 | ma-ah | 2 |
31 | non-standardization | 2 |
32 | piretanide | 2 |
33 | pro-caspase | 2 |
34 | proportion= | 2 |
35 | stent-in | 2 |
36 | teneurin | 2 |
37 | tets | 2 |
38 | 'policies | 1 |
39 | 'so | 1 |
40 | +cholestyramine | 1 |
41 | 1,4:3,6-dianhydride | 1 |
42 | 10+/- | 1 |
43 | 110.2±7.5° | 1 |
44 | 1946-april | 1 |
45 | 2,3,5,4'-tetramethoxystilbene | 1 |
46 | 2,3:22,23-diacetonide | 1 |
47 | 2-hydroxynaphthoquinone | 1 |
48 | 2-methyl-3-yne-1,2-diols | 1 |
49 | 2001-january | 1 |
50 | 2005-10 | 1 |
51 | 3-aryl-3-hydroxy-2-oxindole | 1 |
52 | 3-oxo-delta | 1 |
53 | 4/+ | 1 |
54 | 58:306-318 | 1 |
55 | 75± | 1 |
56 | actrapid | 1 |
57 | afigya | 1 |
58 | agency-initiated | 1 |
59 | ak/pcont | 1 |
60 | annotates | 1 |
61 | bacteria/cod | 1 |
62 | c-peptide0-120 | 1 |
63 | chitogauze | 1 |
64 | chlordesmethyldiazepam | 1 |
65 | cocain | 1 |
66 | deltadpb | 1 |
67 | diacetonide | 1 |
68 | dihydroavicine | 1 |
69 | dihydronitidine | 1 |
70 | dolastatin | 1 |
71 | draculin-like | 1 |
72 | e2/ | 1 |
73 | enterocoating | 1 |
74 | erg/cm | 1 |
75 | estradiol-depot | 1 |
76 | ethane-1,2-dithiolate | 1 |
77 | fenianyl | 1 |
78 | fluo | 1 |
79 | frill | 1 |
80 | fruits/vegetables/cod | 1 |
81 | g2- | 1 |
82 | g5- | 1 |
83 | gallicin | 1 |
84 | ginsengisoli | 1 |
85 | glp- | 1 |
86 | hep3bpn | 1 |
87 | heterogeneity.part | 1 |
88 | hprp | 1 |
89 | il1b+ | 1 |
90 | intention-to-stent | 1 |
91 | kaempferol-7-o-rhamnoside | 1 |
92 | kdqol-sftm | 1 |
93 | large-intestine | 1 |
94 | leafy-stem | 1 |
95 | lidocaine-adrenaline | 1 |
96 | lifestart | 1 |
97 | lssue | 1 |
98 | ma-l | 1 |
99 | matrixmetalloproteinase | 1 |
100 | meliastatin | 1 |
101 | mtap | 1 |
102 | murf | 1 |
103 | n-cpap/n-bipap | 1 |
104 | neuroreport | 1 |
105 | non-atpase | 1 |
106 | non-tfpi | 1 |
107 | non-trimmed | 1 |
108 | nor-secotriterpene | 1 |
109 | nrap | 1 |
110 | o-dirhamnoside | 1 |
111 | obscurin-like | 1 |
112 | oxyavicine | 1 |
113 | oxynitidine | 1 |
114 | podophylin | 1 |
115 | posiformin® | 1 |
116 | post-rssa | 1 |
117 | procollagen-type | 1 |
118 | prokineticin | 1 |
119 | prq85-part | 1 |
120 | quercetin-6,4'-dimethoxy-3-fructo-rhamnoside | 1 |
121 | questionnaire-9-calculated | 1 |
122 | r-spondin | 1 |
123 | r=0.127 | 1 |
124 | rear/forward | 1 |
125 | rmald | 1 |
126 | sesquiterpenoid-alkaloid | 1 |
127 | so- | 1 |
128 | sonde | 1 |
129 | stress-induced-phosphoprotein | 1 |
130 | sulfonylhydrazides | 1 |
131 | sweets/cod | 1 |
132 | tef- | 1 |
133 | tele-supervised | 1 |
134 | toothbrush/cod | 1 |
135 | tvv- | 1 |
136 | verlindamycin | 1 |
137 | vivastyle® | 1 |
138 | world.act | 1 |
139 | xinming | 1 |
140 | yì | 1 |
141 | zf-3-ost-2 | 1 |
142 | β-glycoprotein | 1 |
143 | ≥gleason | 1 |
1 | 'policies | 1 |
2 | 'so | 1 |
3 | 'stage | 3 |
4 | +cholestyramine | 1 |
5 | 1,4:3,6-dianhydride | 1 |
6 | 10+/- | 1 |
7 | 110.2±7.5° | 1 |
8 | 16:1cis | 2 |
9 | 1946-april | 1 |
10 | 1966-week | 2 |
11 | 1982-week | 2 |
12 | 2,3,5,4'-tetramethoxystilbene | 1 |
13 | 2,3:22,23-diacetonide | 1 |
14 | 2-hydroxynaphthoquinone | 1 |
15 | 2-methyl-3-yne-1,2-diols | 1 |
16 | 2001-january | 1 |
17 | 2005-10 | 1 |
18 | 3-aryl-3-hydroxy-2-oxindole | 1 |
19 | 3-oxo-delta | 1 |
20 | 4-hydroxyacetophenone | 2 |
21 | 4/+ | 1 |
22 | 58:306-318 | 1 |
23 | 75± | 1 |
24 | actrapid | 1 |
25 | afigya | 1 |
26 | agency-initiated | 1 |
27 | ak/pcont | 1 |
28 | anhelto | 6 |
29 | annotates | 1 |
30 | bacteria/cod | 1 |
31 | c-peptide0-120 | 1 |
32 | caspase- | 2 |
33 | chitogauze | 1 |
34 | chlordesmethyldiazepam | 1 |
35 | cocain | 1 |
36 | conservativeness | 3 |
37 | deltadpb | 1 |
38 | diacetonide | 1 |
39 | diacetylene | 3 |
40 | dihydroavicine | 1 |
41 | dihydronitidine | 1 |
42 | dolastatin | 1 |
43 | draculin-like | 1 |
44 | e2/ | 1 |
45 | e2/e4 | 2 |
46 | enterocoating | 1 |
47 | erg/cm | 1 |
48 | erythroid-derived | 20 |
49 | estradiol-depot | 1 |
50 | ethane-1,2-dithiolate | 1 |
51 | evidence.comparison | 2 |
52 | ex-b | 104 |
53 | ex-le | 22 |
54 | fenianyl | 1 |
55 | fluo | 1 |
56 | frill | 1 |
57 | fruits/vegetables/cod | 1 |
58 | g2- | 1 |
59 | g5- | 1 |
60 | gallicin | 1 |
61 | ginsengisoli | 1 |
62 | glp- | 1 |
63 | gravida | 93 |
64 | hemeoxygenase | 2 |
65 | hep3bpn | 1 |
66 | heterogeneity.part | 1 |
67 | hprp | 1 |
68 | il1b+ | 1 |
69 | intention-to-stent | 1 |
70 | isar-test | 11 |
71 | issue | 7,893 |
72 | junctophilin | 2 |
73 | kaempferol-7-o-rhamnoside | 1 |
74 | kdqol-sftm | 1 |
75 | kinase/pentraxin | 2 |
76 | large-intestine | 1 |
77 | leafy-stem | 1 |
78 | lidocaine-adrenaline | 1 |
79 | lifestart | 1 |
80 | lssue | 1 |
81 | ma-ah | 2 |
82 | ma-l | 1 |
83 | matrixmetalloproteinase | 1 |
84 | meliastatin | 1 |
85 | mtap | 1 |
86 | murf | 1 |
87 | n-cpap/n-bipap | 1 |
88 | neurofunction | 3 |
89 | neuroreport | 1 |
90 | nih/cpsi | 5 |
91 | non-atpase | 1 |
92 | non-standardization | 2 |
93 | non-tfpi | 1 |
94 | non-trimmed | 1 |
95 | nor-secotriterpene | 1 |
96 | nrap | 1 |
97 | o-dirhamnoside | 1 |
98 | obscurin-like | 1 |
99 | oxyavicine | 1 |
100 | oxynitidine | 1 |
101 | pappalysin | 3 |
102 | piretanide | 2 |
103 | podophylin | 1 |
104 | posiformin® | 1 |
105 | post-rssa | 1 |
106 | postwrap | 4 |
107 | pro-caspase | 2 |
108 | procollagen-type | 1 |
109 | prokineticin | 1 |
110 | proportion= | 2 |
111 | prq85-part | 1 |
112 | quercetin-6,4'-dimethoxy-3-fructo-rhamnoside | 1 |
113 | questionnaire-9-calculated | 1 |
114 | r-spondin | 1 |
115 | r=0.127 | 1 |
116 | rear/forward | 1 |
117 | rmald | 1 |
118 | sesquiterpenoid-alkaloid | 1 |
119 | so- | 1 |
120 | sonde | 1 |
121 | spondin | 3 |
122 | stent-in | 2 |
123 | stress-induced-phosphoprotein | 1 |
124 | sulfonylhydrazides | 1 |
125 | sweets/cod | 1 |
126 | tef- | 1 |
127 | tele-supervised | 1 |
128 | teneurin | 2 |
129 | tets | 2 |
130 | texturing | 3 |
131 | toothbrush/cod | 1 |
132 | tvv- | 1 |
133 | uht-processed | 3 |
134 | verlindamycin | 1 |
135 | vivastyle® | 1 |
136 | wn02 | 5 |
137 | world.act | 1 |
138 | wrat | 3 |
139 | xinming | 1 |
140 | yì | 1 |
141 | zf-3-ost-2 | 1 |
142 | β-glycoprotein | 1 |
143 | ≥gleason | 1 |
1 | 4/+ | 1 |
2 | il1b+ | 1 |
3 | 10+/- | 1 |
4 | g2- | 1 |
5 | g5- | 1 |
6 | caspase- | 2 |
7 | tef- | 1 |
8 | so- | 1 |
9 | glp- | 1 |
10 | tvv- | 1 |
11 | e2/ | 1 |
12 | 2005-10 | 1 |
13 | c-peptide0-120 | 1 |
14 | zf-3-ost-2 | 1 |
15 | wn02 | 5 |
16 | e2/e4 | 2 |
17 | r=0.127 | 1 |
18 | 58:306-318 | 1 |
19 | proportion= | 2 |
20 | gravida | 93 |
21 | post-rssa | 1 |
22 | 3-oxo-delta | 1 |
23 | afigya | 1 |
24 | ex-b | 104 |
25 | deltadpb | 1 |
26 | non-trimmed | 1 |
27 | tele-supervised | 1 |
28 | uht-processed | 3 |
29 | agency-initiated | 1 |
30 | questionnaire-9-calculated | 1 |
31 | erythroid-derived | 20 |
32 | sesquiterpenoid-alkaloid | 1 |
33 | actrapid | 1 |
34 | rmald | 1 |
35 | bacteria/cod | 1 |
36 | toothbrush/cod | 1 |
37 | fruits/vegetables/cod | 1 |
38 | sweets/cod | 1 |
39 | rear/forward | 1 |
40 | piretanide | 2 |
41 | diacetonide | 1 |
42 | 2,3:22,23-diacetonide | 1 |
43 | 1,4:3,6-dianhydride | 1 |
44 | kaempferol-7-o-rhamnoside | 1 |
45 | quercetin-6,4'-dimethoxy-3-fructo-rhamnoside | 1 |
46 | o-dirhamnoside | 1 |
47 | sonde | 1 |
48 | 'stage | 3 |
49 | draculin-like | 1 |
50 | obscurin-like | 1 |
51 | ex-le | 22 |
52 | 3-aryl-3-hydroxy-2-oxindole | 1 |
53 | 2,3,5,4'-tetramethoxystilbene | 1 |
54 | diacetylene | 3 |
55 | nor-secotriterpene | 1 |
56 | dihydroavicine | 1 |
57 | oxyavicine | 1 |
58 | dihydronitidine | 1 |
59 | oxynitidine | 1 |
60 | lidocaine-adrenaline | 1 |
61 | +cholestyramine | 1 |
62 | large-intestine | 1 |
63 | 4-hydroxyacetophenone | 2 |
64 | 2-hydroxynaphthoquinone | 1 |
65 | procollagen-type | 1 |
66 | hemeoxygenase | 2 |
67 | matrixmetalloproteinase | 1 |
68 | pro-caspase | 2 |
69 | non-atpase | 1 |
70 | ethane-1,2-dithiolate | 1 |
71 | issue | 7,893 |
72 | lssue | 1 |
73 | chitogauze | 1 |
74 | murf | 1 |
75 | xinming | 1 |
76 | texturing | 3 |
77 | enterocoating | 1 |
78 | ma-ah | 2 |
79 | ginsengisoli | 1 |
80 | non-tfpi | 1 |
81 | nih/cpsi | 5 |
82 | 1982-week | 2 |
83 | 1966-week | 2 |
84 | ma-l | 1 |
85 | 1946-april | 1 |
86 | frill | 1 |
87 | fenianyl | 1 |
88 | chlordesmethyldiazepam | 1 |
89 | erg/cm | 1 |
90 | leafy-stem | 1 |
91 | kdqol-sftm | 1 |
92 | stent-in | 2 |
93 | cocain | 1 |
94 | gallicin | 1 |
95 | prokineticin | 1 |
96 | verlindamycin | 1 |
97 | spondin | 3 |
98 | r-spondin | 1 |
99 | β-glycoprotein | 1 |
100 | stress-induced-phosphoprotein | 1 |
101 | junctophilin | 2 |
102 | podophylin | 1 |
103 | teneurin | 2 |
104 | pappalysin | 3 |
105 | meliastatin | 1 |
106 | dolastatin | 1 |
107 | kinase/pentraxin | 2 |
108 | non-standardization | 2 |
109 | neurofunction | 3 |
110 | ≥gleason | 1 |
111 | evidence.comparison | 2 |
112 | hep3bpn | 1 |
113 | 'so | 1 |
114 | anhelto | 6 |
115 | fluo | 1 |
116 | n-cpap/n-bipap | 1 |
117 | nrap | 1 |
118 | postwrap | 4 |
119 | mtap | 1 |
120 | hprp | 1 |
121 | sulfonylhydrazides | 1 |
122 | 'policies | 1 |
123 | annotates | 1 |
124 | 16:1cis | 2 |
125 | 2-methyl-3-yne-1,2-diols | 1 |
126 | conservativeness | 3 |
127 | tets | 2 |
128 | wrat | 3 |
129 | world.act | 1 |
130 | intention-to-stent | 1 |
131 | ak/pcont | 1 |
132 | estradiol-depot | 1 |
133 | prq85-part | 1 |
134 | heterogeneity.part | 1 |
135 | lifestart | 1 |
136 | neuroreport | 1 |
137 | isar-test | 11 |
138 | 2001-january | 1 |
139 | yì | 1 |
140 | vivastyle® | 1 |
141 | posiformin® | 1 |
142 | 110.2±7.5° | 1 |
143 | 75± | 1 |